- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03870932
Effects of a Motor Imagery Exercise Protocol in Patients With Fibromyalgia
May 12, 2019 updated by: Teresa Paolucci, University of Roma La Sapienza
Effects of a Motor Imagery Exercise Protocol on Chronic Pain and Emotional Distress in Patients With Fibromyalgia: a Pilot Study
The aim of this study was to evaluate the efficacy of a novel approach with a motor imagery-based exercise program versus conventional rehabilitative approach in fibromyalgia syndrome (FM): reduction of pain was set as the primary outcome.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Evidence about the therapeutic efficacy of exercise intervention programs in FM is still low and many authors suggested improving standardized exercise prescription for FM to achieve optimal results.
In the literature, as an alternative approach, rehabilitative protocols in Group Music and Imagery seem to improve well-being and reduce anxiety in women with FM and suggest that Music and Imagery may help diminish pain intensity and depression.
A rehabilitative approach should also consider the psychological and emotional aspects and, when possible, be accompanied by cognitive-behavioral therapy.
The purpose of this research is to evaluate the possible efficacy of a novel approach with a motor imagery-based exercise program versus conventional rehabilitative approach in FM syndrome: the reduction of pain was set as the primary outcome as well as taking into account the patient's psychological and emotional condition.
This study was designed as a double-blind, randomized, controlled trial.
Study Type
Interventional
Enrollment (Actual)
29
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rome, Italy, 00165
- Umberto I Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- experienced widespread pain for more than 3 months
- pain with 4 kg/cm2 pressure at 11 or more of the 18 tender points
- aged 18 to 60 years
- pharmacological therapeutic regimen must have been stable for at least three months before
Exclusion Criteria:
- pregnant women
- pacemaker wearers
- overlapping painful conditions
- presence of autoimmune or hematologic diseases
- psychiatric disorders in pharmacological and psychological treatment
- other causes of chronic pain
- other diseases such as epilepsy, tumors, major neurological problems and diabetes
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Motor imagery rehabilitative group (MIG)
All patients performed 10 treatment sessions, lasting 60 to 90 minutes, twice a week, in groups of three to four patients.
The gold standard was to choose simple and safe exercises in order to encourage the patient to repeat the schedule at home.
The exercises proposed in the MIG have been chosen respecting the following principles: slowness, painlessness, promoting attention, easy to imagine.
The main purpose of motor imagery-based exercises was to bring the patient back to "feeling and self-perceiving" the execution of the movement.
More than the "quantity" of repetition, the "quality" of the movement, free from pain, was important.
|
|
|
Active Comparator: Control rehabilitative Group (CG)
The CG received a conventional rehabilitation protocol, based on ten 1-hour sessions, held twice a week (over a 5-week period), previously investigated as efficient in FM by the authors and published.
The exercises included low-to-moderate impact aerobic training, walking in a circle, alternating with periods of going up and down the stairs (3 steps for 10 minutes), for a total of 20 consecutive minutes, posture exercises for the back and proprioceptive exercises for the trunk, to improve axial stability.
Each exercise was repeated 10 times (3 sets of 10), with a resting period of at least 3 minutes between sets.
All sessions ended with stretching and diaphragmatic breathing exercises.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Fibromyalgia Impact Questionnaire (FIQ)
Time Frame: 0-4-12 weeks
|
self-administered instrument to assess the current health status of patients with fibromyalgia
|
0-4-12 weeks
|
|
Health Assessment Questionnaire (HAQ)
Time Frame: 0-4-12 weeks
|
comprehensive measure of outcome in patients with a wide variety of chronic diseases
|
0-4-12 weeks
|
|
Fibromyalgia Assessment Status (FAS)
Time Frame: 0-4-12 weeks
|
self-administered index that combines fatigue, sleep disturbances and pain in 16 non-articular sites
|
0-4-12 weeks
|
|
Visual Analogue Scale (VAS)
Time Frame: 0-4-12 weeks
|
Instrument to assess unidimensional measure of pain intensity.
VAS was presented in a coloured scale with a middle point, graduations and numbers.
Under the scale there was a straight horizontal line of fixed length, 100 mm.
The ends were defined as the limits of the parameter to be measured (pain in the last 24 hours), orientated from the left (worst, no pain) to the right (best, worst pain to be imagined).
The score is determined by measuring the distance (cm) on the 10 cm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-10.
|
0-4-12 weeks
|
|
Hamilton Anxiety Rating Scale (HAM-A)
Time Frame: 0-4-12 weeks
|
Instrument to assess anxiety severity.
The HAM-A was one of the first rating scales developed to measure the severity of anxiety symptoms.
The scale consists of 14 items, each defined by a series of symptoms, and measures both psychic anxiety (mental agitation and psychological distress) and somatic anxiety (physical complaints related to anxiety).
Each item is scored on a scale of 0 (not present) to 4 (severe), with a total score range of 0-56, where <17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe.
It was administered by a clinician experienced in working with psychiatric patients.
|
0-4-12 weeks
|
|
Hamilton Depression Scale (HAM-D)
Time Frame: 0-4-12 weeks
|
Otherwise known as Hamilton Rating Scale for Depression or HRSD-17.
The patient is rated by a clinician on 21 items scored either on a 3-point or 5-point Likert-type scale.
Although the form lists 21 items, the scoring is based on the first 17.
It generally takes 15-20 minutes to complete the interview and score the results.
Eight items are scored on a 5-point scale, ranging from 0 = not present to 4 = severe.
Nine are scored from 0-2.
A score of 0-7 is considered to be normal while a score of 20 or higher indicates at least moderate severity.
|
0-4-12 weeks
|
|
20-Item Toronto Alexithymia Scale (TAS-20)
Time Frame: 0-4-12 weeks
|
Instrument to assess alexithymia severity.
The TAS is a 20-item instrument with 3 subscales: 1) difficulty Describing Feelings subscale, is used to measure difficulty describing emotions.
5 items; 2) difficulty Identifying Feeling subscale is used to measure difficulty identifying emotions.
7 items; 3) Externally-Oriented Thinking subscale, is used to measure the tendency of individuals to focus their attention externally.
8 items.
The scale is a self-report scale that is comprised of 20 items.
Items are rated using a 5-point Likert scale whereby 1 = strongly disagree and 5 = strongly agree.
There are 5 items that are negatively keyed (items 4, 5, 10, 18 and 19).
The total alexithymia score is the sum of responses to all 20 items, while the score for each subscale factor is the sum of the responses to that subscale.
The TAS-20 uses cutoff scoring: equal to or less than 51 = non-alexithymia, equal to or greater than 61 = alexithymia.
Scores of 52 to 60 = possible alexithymia.
|
0-4-12 weeks
|
|
Coping Orientation to the Problems Experienced (COPE-NIV)
Time Frame: 0-4-12 weeks
|
instrument for measuring a broad range of coping styles
|
0-4-12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Teresa Paolucci, MD, PhD, Università "Sapienza" Roma
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2016
Primary Completion (Actual)
December 15, 2017
Study Completion (Actual)
August 30, 2018
Study Registration Dates
First Submitted
March 10, 2019
First Submitted That Met QC Criteria
March 10, 2019
First Posted (Actual)
March 12, 2019
Study Record Updates
Last Update Posted (Actual)
May 14, 2019
Last Update Submitted That Met QC Criteria
May 12, 2019
Last Verified
May 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- URomLS-2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
Selcuk UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...CompletedFibromyalgia (FM)Spain
-
Istanbul Gelisim UniversityBahçeşehir UniversityCompleted
-
Gazi UniversityCompletedFibromyalgia SyndromeTurkey (Türkiye)
-
Ionclinics & Deionic SLHospital Clínico Universitario de ValenciaNot yet recruitingFibromyalgia (FM)Spain
-
Ain Shams UniversityRecruiting
-
University of UtahRecruitingFibromyalgia (FM)United States
-
María Catalina Osuna PérezActive, not recruitingFibromyalgia SyndromeSpain
-
Istanbul UniversityCompletedFibromyalgia | Fibromyalgia Syndrome | Fibromyalgia (FM)Turkey (Türkiye)
Clinical Trials on Motor Imagery physical therapy
-
Riphah International UniversityCompleted
-
Alanya Alaaddin Keykubat UniversityPamukkale University; Alanya Allaaddin Keykubat University Hospital; Alanya Hamdullah...SuspendedShoulder Pain | Rotator Cuff Tears | Patient Satisfaction | Atrophy, Muscular | Motor Imagery | Kinesiophobia | Muscle ActivityTurkey (Türkiye)
-
Riphah International UniversityCompletedQuality of Life | Gait, Hemiplegic | Spasticity as Sequela of StrokePakistan
-
Science and Research Centre KoperSlovenian Research AgencyCompletedOsteo Arthritis Knee | Knee ArthroplastySlovenia
-
Riphah International UniversityCompleted
-
Riphah International UniversityRecruitingPain | Cervical Pain | KinesiophobiaPakistan
-
Cairo UniversityRecruitingCerebral Palsy, SpasticEgypt
-
Riphah International UniversityCompletedCerebral PalsyPakistan
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityRecruitingSpastic Diplegia | Motor ImageryEgypt